(Q30809665)

26 June 2017

title

99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study (English)

1 reference

26 June 2017

Clemens Decristoforo

1

1 reference

26 June 2017

Theodosia Maina

2

1 reference

26 June 2017

Berthold Nock

3

1 reference

26 June 2017

Michael Gabriel

4

1 reference

26 June 2017

Paul Cordopatis

5

1 reference

26 June 2017

Roy Moncayo

6

1 reference

26 June 2017

language of work or name

1 reference

4 July 2003

1 reference

26 June 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

26 June 2017

volume

30

1 reference

26 June 2017

issue

9

1 reference

26 June 2017

page(s)

1211-1219

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-003-1225-y

26 June 2017

exact match

0 references

cites work

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

1 reference

12 December 2020

Peptide receptor imaging and therapy

1 reference

12 December 2020

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

12 December 2020

Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.

1 reference

12 December 2020

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

1 reference

12 December 2020

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

12 December 2020

Sandostatin labeled with 99mTc: in vitro stability, in vivo validity and comparison with 111In-DTPA-octreotide

1 reference

12 December 2020

Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides

1 reference

12 December 2020

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

1 reference

12 December 2020

Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy

1 reference

12 December 2020

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

1 reference

12 December 2020

Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m.

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Synthesis and biological evaluation of Tc-99m-cyclopentadienyltricarbonyltechnetium-labeled octreotide

1 reference

12 December 2020

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.

1 reference

12 December 2020

Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands

1 reference

12 December 2020

[Somatostatin receptor scintigraphy. Methodology, indications, results]

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

10.1007/S00259-003-1225-Y

Identifiers

DOI

1 reference

26 June 2017

1 reference